- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Adequate Colonoscopy Preparation for Inpatients in Spain
Total 24 results
-
Corporacion Parc TauliUnknownBowel Preparation for ColonoscopySpain
-
Casen Recordati S.L.CompletedBowel Preparation for ColonoscopySpain
-
Parc de Salut MarHospital Universitario de CanariasCompletedBowel Preparation for ColonoscopySpain
-
Fundación Canaria Rafael Clavijo para la Investigación...CompletedColonoscopy PreparationSpain
-
Hospital San Juan de Dios TenerifeUnknownAmbulatory Patients Referred for a First-time ColonoscopySpain
-
Laboratorios Casen-Fleet S.L.U.Apices Soluciones S.L.; Trial Form Support S.L.CompletedSubjects Undergoing a Complete Exploratory Diagnostic Colonoscopy for the First Time.Spain
-
Fundación para la Investigación del Hospital Clínico...Completed
-
Fundación para la Investigación del Hospital Clínico...CompletedPatients With ASA Status I-III Scheduled for Elective SurgerySpain
-
Hospital Clinic of BarcelonaAstraZenecaCompletedPatients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion)Spain
-
Zimmer BiometActive, not recruitingAvascular Necrosis | Inflammatory Arthritis | Osteoarthritis, Hip | Congenital Hip Dysplasia | Post-traumatic; Arthrosis | Rheumatoid Arthritis With Adequate Bone QualityNetherlands, Finland, Belgium, France, Spain, Australia, Canada, United Kingdom
-
Universidad Católica San Antonio de MurciaCompleted
-
Universidad Católica San Antonio de MurciaCompleted
-
Universidad Católica San Antonio de MurciaUnknownPatients With HaemophiliaSpain
-
Parc Sanitari Pere VirgiliConsorci Sanitari Integral; Vall d'Hebron Institute of Research; Health and Ageing... and other collaboratorsRecruitingPatients (>=60 Years Old) Suffering From Mild-moderate Stroke (Ischemic or Hemorrhagic, Stroke Severity Assessed by NIHSS <16 Points)Spain, Sweden
-
Parc Sanitari Pere VirgiliAlthaia Xarxa Assistencial Universitària de Manresa; Hospital Vall d'Hebron; Consorci... and other collaboratorsCompletedPatients Aged 65-85 (Both Included) | Diagnosed of Mild Cognitive Impairment | Diagnosed of Type 2 Diabetes in Active Treatment (Hypoglycemic Agents) for a Period ≥5 YearsSpain
-
LivaNovaCompletedAssess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients.Italy, France, Spain, United States, Germany, United Kingdom
-
Medtronic Heart ValvesCompletedDysfunctional RVOT Conduits in Patients With Congenital Heart DefectsSpain, United States, Austria, Canada
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
Boston Scientific CorporationCompletedPatients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, StrokeIreland, Spain, Germany, Netherlands, France, United Kingdom, Italy, Russian Federation, Portugal, Belgium, Poland, Saudi Arabia, United Arab Emirates
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B | Relatives to/Carers of PatientsSpain, Canada, United Kingdom
-
Boston UniversityNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingBicuspid Aortic Valve Disease | Thoracic Aortic Disease in Patients With a Bicuspid Aortic ValveUnited States, Spain, United Kingdom, Canada, Italy
-
AstraZenecaCompletedEGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.Italy, Spain, United Kingdom, Sweden, Japan, Netherlands, Germany, France
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe Patients Untreated or Treated With rhGAASpain, Slovenia, Serbia, Korea, Republic of, Greece, Australia, Singapore, Brazil, Canada, Taiwan, Ireland, Poland, Romania
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria